Brown Brothers Harriman & Co. »

Nektar Therapeutics shares owned by Brown Brothers Harriman & Co.

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by Brown Brothers Harriman & Co. from 13F filings

Historical chart of Brown Brothers Harriman & Co. investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by Brown Brothers Harriman & Co. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by Brown Brothers Harriman & Co.

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.8k 66 56.89
2025-06-30 $1.7k 66 25.83

More positions owned by Brown Brothers Harriman & Co.

Microsoft Corp Common Stock (MSFT)
Alphabet Inc-cl C Common Stock (GOOG)
Oracle Corp Common Stock (ORCL)
Ishares Core S&p 500 Etf Common Stock (IVV)
Kla Corp Common Stock (KLAC)
Berkshire Hathaway Inc-cl B Common Stock (BRK.B)
Apple Common Stock (AAPL)
Mastercard Inc - A Common Stock (MA)
Amazon.com Common Stock (AMZN)
Waste Management Common Stock (WM)
Linde Common Stock (LIN)
Booking Holdings Common Stock (BKNG)
Arthur J Gallagher & Co Common Stock (AJG)
Nvidia Corp Common Stock (NVDA)
Zoetis Common Stock (ZTS)

View all positions for Brown Brothers Harriman & Co.

Top funds holding Nektar Therapeutics

Susquehanna International
BVF
Vanguard Group
Citadel Advisors
Farallon Capital Management
BlackRock
Millennium Management
Two Sigma Investments
Nantahala Capital Management
22NW
Emerald Advisers
Leucadia National Corporation
Dr. Jeffrey R. Jay, M.D.
PRIMECAP Management Company
Renaissance Technologies

View all funds holding Nektar Therapeutics